Hospital operators hoped the need for temporary nursing staff and heightened labor costs would ease alongside dwindling cases of the omicron variant, as they did during previous waves. That wasn’t the case in the first quarter.
The central issue of the new lawsuit is the guidance the federal government has provided to third-party arbiters.
The expansion of health coverage to more Americans reflects pandemic-related policy efforts, but some of those flexibilities are set to expire this year.
Between new locations, expanding programs and an ever-growing list of community service initiatives, Touro University is becoming one of the nation’s leaders in medical and health science education in myriad ways.
Political ire around direct contracting that came to a head earlier this year was rooted in a “real lack of understanding,” one CEO of a physician group said Friday at NAACOS’ spring conference.
As it saw a decline in pandemic-related waste, Stericycle experienced its most acute period of driver illnesses yet. The company also previewed a new medical waste facility and closed out a $90 million corruption settlement.
The report calls for improved oversight of MA and urges the CMS to update audit protocols and issue new guidance on medical necessity reviews performed by the plans.
Bristol Myers paid $13 billion to acquire the drug’s maker, MyoKardia, and expects it to become a blockbuster. But a tricky dosing regimen, as well as safety concerns, could challenge the pharmaceutical giant’s lofty forecast.
Wright Lassiter will succeed Lloyd Dean, who announced his intent to retire last year, setting off a nationwide executive search.
The lab and medtech groups joined a coalition of more than 60 organizations warning congressional leaders the funding expiration puts “the most vulnerable” Americans at risk of losing resources to diagnose new infections.